Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. (original) (raw)

Research Article Free access | 10.1172/JCI114376

N I Stocks, R A Zajac, R N Boswell, D R Lucey, C S Via, and G M Shearer

Experimental Immunology Branch, National Cancer Institute, Bethesda, Maryland 20892.

Find articles by Clerici, M. in:JCI |PubMed |Google Scholar

Experimental Immunology Branch, National Cancer Institute, Bethesda, Maryland 20892.

Find articles by Stocks, N. in:[JCI](/search/results?q=author.first%5Fname%3A%22N I%22+author.last%5Fname%3A%22Stocks%22&search%5Ftype=advanced) |PubMed |Google Scholar

Experimental Immunology Branch, National Cancer Institute, Bethesda, Maryland 20892.

Find articles by Zajac, R. in:[JCI](/search/results?q=author.first%5Fname%3A%22R A%22+author.last%5Fname%3A%22Zajac%22&search%5Ftype=advanced) |PubMed |Google Scholar

Experimental Immunology Branch, National Cancer Institute, Bethesda, Maryland 20892.

Find articles by Boswell, R. in:[JCI](/search/results?q=author.first%5Fname%3A%22R N%22+author.last%5Fname%3A%22Boswell%22&search%5Ftype=advanced) |PubMed |Google Scholar

Experimental Immunology Branch, National Cancer Institute, Bethesda, Maryland 20892.

Find articles by Lucey, D. in:[JCI](/search/results?q=author.first%5Fname%3A%22D R%22+author.last%5Fname%3A%22Lucey%22&search%5Ftype=advanced) |PubMed |Google Scholar

Experimental Immunology Branch, National Cancer Institute, Bethesda, Maryland 20892.

Find articles by Via, C. in:[JCI](/search/results?q=author.first%5Fname%3A%22C S%22+author.last%5Fname%3A%22Via%22&search%5Ftype=advanced) |PubMed |Google Scholar

Experimental Immunology Branch, National Cancer Institute, Bethesda, Maryland 20892.

Find articles by Shearer, G. in:[JCI](/search/results?q=author.first%5Fname%3A%22G M%22+author.last%5Fname%3A%22Shearer%22&search%5Ftype=advanced) |PubMed |Google Scholar

Published December 1, 1989 -More info

Published December 1, 1989 -Version history

View PDF

Abstract

We have tested the T helper cell (TH) potential of asymptomatic, HIV seropositive (HIV+) patients, using an in vitro assay for IL-2 production. Peripheral blood leukocytes (PBL) from 74 HIV+ patients and 70 HIV- control donors were tested for TH function when stimulated with influenza A virus (FLU), tetanus toxoid (TET), HLA alloantigens (ALLO), or PHA. Of the HIV+ patients, four different response patterns were observed: (a) patients who responded to all four stimuli (16%); (b) patients who were selectively unresponsive to FLU and TET, but responded to ALLO and PHA (54%); (c) patients who were unresponsive to FLU, TET, or ALLO, but responsive to PHA (16%); and (d) patients who failed to respond to any of these stimuli (14%). Our results indicate a time-dependent progression from a stage responsive to all four stimuli to a stage unresponsive to any of the stimuli tested, progressing in the order outlined above. The earliest TH defect is the loss of responses to FLU and TET, indicating a selective defect in CD4+ MHC self-restricted TH function. The later loss of ALLO and PHA IL-2 responses suggests more severe TH dysfunction involving both CD4+ and CD8+ T cells. None of these patterns of TH unresponsiveness in asymptomatic HIV+ individuals were correlated with CD4+ cell numbers nor with Walter Reed staging criteria. This study indicates that the in vitro TH assay used can detect multiple stages of immune dysregulation early in the course of HIV infection and raises the possibility that staging of HIV+ patients should include in vitro TH functional analyses of the type described here.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history